Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Wyeth is now a wholly owned subsidiary of Pfizer
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Outpatients
Men and women 18 to 75 years of age, inclusive. Sexually active women participating in the study must use a medically acceptable form of contraception (Medically acceptable forms of contraception include oral contraceptives, injectable or implantable methods, intrauterine devices, or properly used barrier contraception)
Subjects must have a primary diagnosis of MDD based on the criteria in the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV), single or recurrent episode, without psychotic features (If other allowable psychiatric diagnoses are present, MDD must be the predominant psychiatric disorder present.)
You may not be if
Treatment with DVS-233 SR at any time in the past
Treatment with venlafaxine (immediate release \[IR\] or ER) within 90 days of study day 1
Known hypersensitivity to venlafaxine (IR or ER)
Clareo Health | Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder
